Early Access Human Lilrb1/cd85j/ilt2 Protein (lil-hm4b1) Pro Version [yr3SR6ge]

Early Access Human Lilrb1/cd85j/ilt2 Protein (lil-hm4b1) Pro Version [yr3SR6ge]

Welcome to our premium Early Access Human Lilrb1/cd85j/ilt2 Protein (lil-hm4b1) Pro Version [yr3SR6ge], a cutting-edge research tool designed for advanced molecular biology studies. This high-quality protein is meticulously produced using state-of-the-art techniques to ensure purity and consistency. With its exceptional purity of 95%, the LIL-HM4B1 protein is an invaluable asset for researchers in immunology, oncology, and other life science disciplines. Its unique combination of LILRB1, CD85j, and ILT2 domains makes it a versatile reagent for various experimental applications.

Product Properties and Specifications

Our Early Access Human Lilrb1/cd85j/ilt2 Protein (lil-hm4b1) Pro Version [yr3SR6ge] is supplied in a lyophilized form, allowing for convenient storage and easy reconstitution. The protein is produced in a mammalian expression system, ensuring optimal functionality and compatibility with a wide range of in vitro and in vivo assays. Key specifications include a molecular weight of approximately 45 kDa and a concentration of 1 mg/mL in PBS buffer. This product is also suitable for use in flow cytometry, ELISA, and immunoprecipitation, making it a versatile choice for researchers with diverse experimental needs.

• High purity of 95% to ensure reliable results
• Lyophilized form for easy storage and reconstitution
• Produced in a mammalian expression system for optimal functionality

Practical Uses and Target Audience

The Early Access Human Lilrb1/cd85j/ilt2 Protein (lil-hm4b1) Pro Version [yr3SR6ge] is an essential tool for researchers investigating the roles of LILRB1, CD85j, and ILT2 in immune regulation and disease progression. Its applications extend to the study of cancer, autoimmunity, and transplantation. Ideal for use in various experimental settings, this protein is suitable for both academic and industrial researchers. Whether you are working on the development of new therapeutic strategies or exploring the basic mechanisms of immune response, the LIL-HM4B1 protein is a reliable and indispensable resource.

• Investigating immune regulation and disease progression
• Developing new therapeutic strategies for cancer, autoimmunity, and transplantation
• Perfect for academic and industrial research in immunology, oncology, and related fields